Status: Recruiting
Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
The REFORM-HF study aims to test a new technology, AquaPass, designed to assist patients experiencing symptoms of fluid overload due to Heart Failure. Patients will wear a lightweight suit that helps remove excess fluids through their sweat. The investigators want to see if the AquaPass system can remove an additional 500mL of fluids during treatment, alongside patients' regular medications like diuretics. Participants will select if to be treated at their home or in the outpatient clinic.
Participants needed: 40
Trial details
Age: 21-80Biological sex: AllType: InterventionalSponsor: AquaPass Medical Ltd.Updated: Sep 19, 2024Locations: 4
Eligibility criteria
Age ≥21 years and < 80 years [+7]
Patient considered to be in the acute worsening of heart failure: Requiring vent... [+16]